6 analysts have expressed a variety of opinions on IDEX (NYSE:IEX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 3 | 1 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 1 | 3 | 1 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $233.17, with a high estimate of $244.00 and a low estimate of $210.00. Observing a downward trend, the current average is 3.05% lower than the prior average price target of $240.50.
The analysis of recent analyst actions sheds light on the perception of IDEX by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Nathan Jones | Stifel | Raises | Buy | $244.00 | $232.00 |
Joseph Giordano | TD Cowen | Lowers | Buy | $230.00 | $240.00 |
Matt Summerville | DA Davidson | Lowers | Neutral | $210.00 | $220.00 |
Bryan Blair | Oppenheimer | Lowers | Outperform | $238.00 | $245.00 |
Deane Dray | RBC Capital | Lowers | Outperform | $236.00 | $250.00 |
Michael Halloran | Baird | Lowers | Outperform | $241.00 | $256.00 |
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of IDEX's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on IDEX analyst ratings.
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: IDEX's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -4.61%. This indicates a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: IDEX's net margin is impressive, surpassing industry averages. With a net margin of 17.51%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 3.89%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): IDEX's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 2.4%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.36.
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.